Administration of CAR-T cells produced from autologous peripheral blood

2 trials

Sponsors

Takahashi Yoshiyuki, Nagoya University

Conditions

CD19 positive acute lymphoblastic leukemiarefractory/relapsed CD19 positive acute lymphoblastic leukemia

Phase 1

Phase I study of piggyBac transposon mediated chimeric antigen receptor gene modified T cells for CD19 positive acute lymphoblastic leukemia

RecruitingJPRN-UMIN000030984

Nagoya Universityrefractory/relapsed CD19 positive acute lymphoblastic leukemia

Start: 2018-03-01Target: 12Updated: 2026-06-29

piggyBac transposon mediated chimeric antigen receptor gene modified T cells for CD19 positive acute lymphoblastic leukemia

Active, not recruitingJPRN-jRCTa040190099

Takahashi YoshiyukiCD19 positive acute lymphoblastic leukemia

Start: 2018-07-03Target: 12Updated: 2026-09-14

Related Papers

A Phase I Study of CD19 Chimeric Antigen Receptor-T Cells Generated By the <i>PiggyBac</i> Transposon Vector for Acute Lymphoblastic Leukemia

Blood2021-11-059 citations